Canadian employers expanding GLP-1 coverage for weight loss: survey
Nearly two-fifths (37 per cent) of Canadian employers cover glucagon-like peptide-1 therapies for both diabetes and weight loss, up from 31 per cent in 2025…
By: Staff July 14, 2026
July 13, 202615:00
Approval of weight loss drug for sleep apnea could create financial risk for plan sponsors: expert
Health Canada’s recent approval of weight loss drug Zepbound as a treatment for obstructive sleep apnea in obese adults could create financial risks for benefits…
Nearly half (45 per cent) of Canadian employees cite cost as the biggest barrier preventing them from accessing mental-health support, according to a new report…
By: Staff July 14, 2026
July 13, 202609:00
Canadian pension risk transfer market reaches $1.8 billion in first half of 2026: report
The Canadian pension risk transfer market’s total 2026 volume is on track to match that of last year, according to a new report by Sun…
By: Staff July 13, 2026
July 9, 202615:00